J&J Raises Annual Forecast After Selling Elan Stake

Johnson & Johnson, the world’s biggest maker of health-care products, more than doubled its earnings in the second quarter after selling its stake in Elan Corp. The company also boosted its profit forecast.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.